Xilio Therapeutics Inc. Soared
Thu, Feb 10, 2022 at 05:33 PM
Xilio Therapeutics Inc. (XLO:NASDAQ) soared at $12.86, representing a gain of 17.8%. The stock got featured on our News Catalysts scanner on Thu, Feb 03, 2022 at 06:47 AM in the 'MISCELLANEOUS' category. From Thu, Jan 27, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
About Xilio Therapeutics Inc. (XLO:NASDAQ)
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 32.71%
- Hudson Capital Inc. (HUSN:NASDAQ), 24.48%
- Vaccinex, Inc. (VCNX:NASDAQ), 24.36%
- China Online Education Group (COE:NYSE), 24.04%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 23.68%
- IronNet Inc. (IRNT:NYSE), 23.08%
- Meten EdtechX Education Group Ltd. (METX:NASDAQ), 20.92%
- Live Ventures Incorporated (LIVE:NASDAQ), 19.81%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 18.79%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 17.77%